💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Advaxis, Inc. (ADXS)
« Back to company indexADXS Chatter Timeline
Stock Ticker for ADXS
Most Active Tweeters for ADXS
| User | Tweets |
|---|---|
| @RakijaFin | 1 |
| @kwhenfinance | 1 |
Recent Tweets for ADXS
 |
@kwhenfinance Advaxis, Inc. Shares Climb Infinity% Past Previous 52-Week High - Market Mover https://t.co/EnN6HFWASL $ADXS #stockmarket #kwhenfinance January 15th 2022, 3:01pm |
 |
@RakijaFin $ADXS Berlin and $SAVA remi googling countries lacking extradition treaties as we speak https://t.co/9I9d8SxzIF January 14th 2022, 7:01pm |
 |
@MarcJacksonLA $ADXS Advaxis Reports Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 https://t.co/zxcQTUdbR2 via @Street_Insider January 11th 2022, 2:01pm |
 |
@vtmtrading Advaxis presents updated clinical data from Phase 1/2 trial of ADXS-503 $ADXS January 11th 2022, 1:01pm |
 |
@OryoJohn $ADXS: Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming Milest… https://t.co/MDf4UqdHVu January 11th 2022, 1:01pm |
 |
@phasefivebot $ADXS Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming Milesto… https://t.co/gA02f6T5vb January 11th 2022, 1:01pm |
 |
@James__BondOO7 RT @stock_titan: $ADXS Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming Milestones htt… January 11th 2022, 1:01pm |
 |
@StockNewsBot2 $ADXS Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming Milesto… https://t.co/sNTYJf8Gb5 January 11th 2022, 1:01pm |
 |
@stock_titan $ADXS Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming Milesto… https://t.co/jGZI4UYCVC January 11th 2022, 1:01pm |
 |
@bthefirsttoknow First out// $ADXS: Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming January 11th 2022, 1:01pm |
 |
@JanieGarner18 $ADXS More member profits. Stay patient and the let the trade play out. https://t.co/Q3yd3bjlJf January 10th 2022, 7:01am |
|
@kwhenfinance Advaxis, Inc. Shares Climb Infinity% Past Previous 52-Week High - Market Mover https://t.co/GrfuqqlsTm $ADXS #stockmarket #kwhenfinance January 9th 2022, 10:01pm |
 |
@WallStHorizon Top earnings announcements After Market today include $ADXS Full list: https://t.co/LP7BXlUiv6 #stockstowatch #earnings January 7th 2022, 7:01pm |
 |
@intratio $ADXS https://t.co/RuLtL92ENl Advaxis, Inc. Our algorithm assessed that this stock price will fall sharply in the s… https://t.co/k0cZoibMo0 January 7th 2022, 2:01pm |
 |
@Michael44344993 RT @craig__percoco: $ADXS Trading high relative volume. January 6th 2022, 2:01pm |
 |
@SylviaW49935245 $ADXS More member profits. Stay patient and the let the trade play out. https://t.co/dfQC9zfHZT January 6th 2022, 5:01am |
|
@kwhenfinance Advaxis, Inc. Shares Climb Infinity% Past Previous 52-Week High - Market Mover https://t.co/Kt8xfP3B1Q $ADXS #stockmarket #kwhenfinance January 6th 2022, 1:01am |
|
@kwhenfinance Advaxis, Inc. Shares Close the Day 45.5% Higher - Daily Wrap https://t.co/zER37B9Z8P $ADXS #stockmarket #kwhenfinance January 6th 2022, 1:01am |
 |
@salmonofken @biotech_watch_ How you feeling about $adxs? January 5th 2022, 10:01pm |
|
@SylviaW49935245 $ADXS More member profits. Stay patient and the let the trade play out,.. https://t.co/dfQC9zfHZT January 5th 2022, 8:01pm |
 |
@BarPotTM ? Strong Trend Momentum? ? Ticker: $ADXS ? +37.997% Profit Opportunity Since First Alert! For real time Momentum A… https://t.co/UgbA82xU8z January 5th 2022, 4:01pm |
 |
@KayNort63226158 $ADXS More member profits. Stay patient and the let the trade play out.. https://t.co/0z29CX70cK January 5th 2022, 10:01am |
|
@BarPotTM ? Strong Trend Momentum? ? Ticker: $ADXS ? +37.997% Profit Opportunity Since First Alert! For real time Momentum A… https://t.co/Db3lgBjf5B January 4th 2022, 4:01pm |
 |
@Gambiste1 RT @bagogig1: ~When I was novice I made a lot of mistakes then I came to know about this C0mmunity.,,.,https://t.co/wPO70jWUbD $adxs $mtcr… January 3rd 2022, 5:01am |
 |
@Elizabe98094563 $ADXS More member profits. Stay patient and the let the trade play out,. https://t.co/ipepDqLYnb January 3rd 2022, 2:01am |
 |
@investor_feed $ADXS 8-K Advaxis (30 Dec, 4:05pm) ? Termination of a Material Definitive Agreement; Financial Statements and… https://t.co/IARJNmvvL1 December 30th 2021, 9:12pm |
 |
@FlashAlert_me $ADXS [15s. delayed] filed form 8-K on December 30, 16:05:44 https://t.co/XiJrQyg7UV December 30th 2021, 9:12pm |
 |
@mos_hope RT @MrBilliums: $ADXS I believe that .53 was the morning flush. https://t.co/gMlL8bsJS5 December 30th 2021, 12:12pm |
|
@mos_hope RT @warrenpuffettt: $adxs this is getting loaded https://t.co/Z6IU62itGh December 30th 2021, 12:12pm |
 |
@alerts_real $ADXS Real price will come out soon; Follow price targets https://t.co/6YesXVngTW December 30th 2021, 7:12am |
|
@intratio $ADXS https://t.co/RuLtL92ENl Advaxis, Inc. Our predictive algorithm has predicted the market value of this company… https://t.co/WRstmkeiSr December 30th 2021, 1:12am |
|
@Elizabe98094563 $ADXS More member profits. Stay patient and the let the trade play out... https://t.co/ipepDqLYnb December 29th 2021, 10:12pm |
 |
@Lucy3370 @Kevin_W81 $adxs some of these reverse mergers have worked out well. Stock looks like it's getting hammered due to tax loss selling December 29th 2021, 5:12pm |
|
@BarPotTM ? Strong Trend Momentum? ? Ticker: $ADXS ? +37.997% Profit Opportunity Since First Alert! For real time Momentum A… https://t.co/9gch5pOsPs December 29th 2021, 4:12pm |
|
@Marklebow4 $ADXS book value is nearly triple what it’s trading at, crazy cheap. December 28th 2021, 8:12pm |
|
@BarPotTM ? Strong Trend Momentum? ? Ticker: $ADXS ? +37.997% Profit Opportunity Since First Alert! For real time Momentum A… https://t.co/yhRejxcIcL December 28th 2021, 4:12pm |
 |
@leona_hardy2 $ADXS For a limited time,, we are opening our trading chat-room to the public https://t.co/ofUWbMby9l December 28th 2021, 11:12am |
|
@anaana08905362 $ADXS Use this community free now and get access to chat rooms, stock alerts, option alerts, portfolios, and more… https://t.co/Yoav1PiS6I December 28th 2021, 5:12am |
|
@Marklebow4 $ADXS not a bad , with upward moment toward close, Huge bidders are in. December 28th 2021, 4:12am |
 |
@TBE_101 $ADXS fools coulda had this over $2.00. you'd rather push a down investment further than mitigating your loss. thats not investing, it's ego December 27th 2021, 6:12pm |
|
@leona_hardy2 $ADXS For a limited time, we are opening our trading chat-room to the public https://t.co/ofUWbMby9l December 27th 2021, 6:12pm |
|
@Gambiste1 RT @lireh55: ~When I was novice I made a lot of mistakes then I came to know about this C0mmunity.,,.,https://t.co/YlltmbPbKM $adxs $mtcr… December 27th 2021, 6:12pm |
|
@Marklebow4 $Adxs CDEL BIDDING December 27th 2021, 4:12pm |
|
@Marklebow4 $Adxs red to dark green coming. December 27th 2021, 2:12pm |
 |
@WendellBowman7 RT @HaihaoG: $IBIO keep voting no on this rs and end up on otc with $ADXS ? December 27th 2021, 8:12am |
|
@WendellBowman7 RT @MarcJacksonLA: $ADXS Advaxis Announces Acceptance for Trading on the OTCQX https://t.co/fIUkw7ldQG December 27th 2021, 8:12am |
|
@WendellBowman7 RT @RUNNGETSOME: $adxs earnings on 27 December I believe ? https://t.co/d1vXwVH1Gf December 27th 2021, 8:12am |
|
@anaana08905362 $ADXS Use this community free now and get access to chat rooms, stock alerts, option alerts, portfolios, and mor… https://t.co/m4eouBA4MH December 27th 2021, 6:12am |
|
@Marklebow4 $adxs News Article Advaxis Reports Will Explore Added Options To Maximize Shareholder Value; Shareholders Approved… https://t.co/TU8ZGbNDMS December 26th 2021, 10:12pm |
 |
@PennySearch $ADXS Jefferies gave ADXS a Hold stock rating on 2020-11-25. Find top penny stocks with PennySearch before the m… https://t.co/d3GwAOWMQk December 26th 2021, 11:12am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?